| Patients in Treatment N = 16,149 | Missing N (%) |
---|---|---|
Age (years), Median (IQR) | 33 (27-40) | 38 (0.2) |
Education (years), Median (IQR) | 6 (3-8) | 1,194 (7.4) |
Gender, N (%) | Â | Â |
   Male | 6,345 (39.3) | 1 (0.01) |
   Female | 9,803 (60.7) |  |
CD4 Count, Median (IQR) | 151 (84-226) | 726 (4.5) |
WHO Stage, N (%) | Â | Â |
   Stage I | 1,927 (11.9) | 1,597 (9.9) |
   Stage II | 2,353 (14.6) |  |
   Stage III | 8,903 (55.1) |  |
   Stage IV | 1,369 (8.5) |  |
Weight (kg), Median (IQR) | 50.5 (45.0-57.0) | 1,857 (11.5) |
Height (m), Median (IQR) | 1.61 (1.56-1.68) | 3,000 (18.6) |